Skip to Content

Isotechnika Selected to Present at International Transplantation Conference

EDMONTON, Alberta - September 24, 2008 (ISA:TSX): Isotechnika Inc. today announced Dr. Cantarovich, a principal investigator from the Company's recently completed Phase 2b kidney transplant trial (PROMISE), has been selected to make a poster presentation at the International Society of Nephrology Nexus Symposium on Transplantation and the Kidney to be held in Rome, Italy, September 25-28, 2008.

Dr. Cantarovich will make his poster presentation titled "Efficacy and Impact on Renal Function of Voclosporin (ISA247): The Phase 2 'PROMISE' Trial in De Novo Renal Transplant Recipients" on Friday, September 26th, 2008.

Posted: September 2008

View comments